FDA Inspection
SpecGx, LLCSpecGx, LLC – FDA Inspection, Sep 18, 2023
Record Details
This FDA Inspection record concerns SpecGx, LLC, with an inspection on September 18, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 3e43114c-0b19-49da-9cf2-9cc14aa3651d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1220234
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of SpecGx, LLC
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 7, 2026 | Not classified | Kansas City District Office | |
| March 16, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 6, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 15, 2019 | Not classified | Kansas City District Office | |
| January 26, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for SpecGx, LLC
- FDA Inspection 1316986 - 2026-05-07
- FDA Inspection 1122446 - 2020-03-16
- FDA Inspection 1085155 - 2019-03-06
- FDA Inspection 1077155 - 2019-01-15
- FDA Inspection 1039082 - 2018-01-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.